Gene · 6558
Papers2,616
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,616
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Bezafibrate treatment rescues neurodevelopmental and neurodegenerative defects in 3D cortical organoid model of MAPT frontotemporal dementia. | Alzheimers Dement | 2025 | 40810332 | PubTator, text mining | PubMed |
| Risk factors for multiple myeloma and its precursor diseases. | Zhong Nan Da Xue Xue Bao Yi Xue Ban | 2025 | 40785671 | PubTator, text mining | PubMed |
| Development and validation of G2M signature-based prognostic model for stratifying colon cancer prognosis. | Discov Oncol | 2025 | 40783878 | PubTator, text mining | PubMed |
| In Vivo and In Vitro Experimental Study Comparing the Effect of a Combination of Sodium Dichloroacetate and Valproic Acid with That of Temozolomide on Adult Glioblastoma. | Int J Mol Sci | 2025 | 40725030 | PubTator, text mining | PubMed |
| Paradoxical action of zolpidem: interplay between dysregulation of the synergetic actions of γ-aminobutyric acid type A receptors and neuronal cotransporters (KCC2/NKCC1). | J Recept Signal Transduct Res | 2025 | 40686063 | PubTator, text mining | PubMed |
| Identification and Characterization of a Novel Biallelic SLC12A2 Variant Associated With Kilquist Syndrome (OMIM #619080). | Am J Med Genet A | 2025 | 40678848 | PubTator, text mining | PubMed |
| Gabaergic signalling in Autism Spectrum disorders (ASD): Role of glial cells and therapeutic perspectives. | Brain Behav Immun | 2025 | 40623670 | PubTator, text mining | PubMed |
| Zolpidem suppresses cortical spreading depolarization and protects against ischemia/reperfusion injury and resulting neurological dysfunctions. | Biomed Pharmacother | 2025 | 40616882 | PubTator, text mining | PubMed |
| Development of a BRET based chloride biosensor for high throughput screening of KCC2 modulators. | SLAS Discov | 2025 | 40570963 | PubTator, text mining | PubMed |
| Growth Factors and the Choroid Plexus: Their Role in Posthemorrhagic Hydrocephalus. | Biomedicines | 2025 | 40564085 | PubTator, text mining | PubMed |
| De Novo SLC12A2 Variant Presenting as Congenital Hearing Loss With Vestibular Areflexia. | Am J Med Genet A | 2025 | 40503591 | PubTator, text mining | PubMed |
| Exosome-derived SLC12A2-DT promotes macrophage M2 polarization-mediated hepatocellular carcinoma progression. | Int Immunopharmacol | 2025 | 40446695 | PubTator, text mining | PubMed |
| Expansion of functional human salivary acinar cell spheroids with reversible thermo-ionically crosslinked 3D hydrogels. | Int J Oral Sci | 2025 | 40346044 | PubTator, text mining | PubMed |
| Comparative evaluation of certain biomarkers emphasizing abnormal GABA inhibitory effect and glutamate excitotoxicity in autism spectrum disorders. | Front Psychiatry | 2025 | 40330649 | PubTator, text mining | PubMed |
| Promoting Polarization and Differentiation of Primary Human Salivary Gland Stem/Progenitor Cells in Protease-Degradable Hydrogels via ROCK Inhibition. | ACS Appl Mater Interfaces | 2025 | 40095914 | PubTator, text mining | PubMed |
| Minigene assay for verifying the splicing effects of the rare variants in the SLC12A2 gene at c.2930-1G>a. | Acta Otolaryngol | 2025 | 40084930 | PubTator, text mining | PubMed |
| Target inhibition of SPAK in choroid plexus attenuates T cell infiltration and demyelination in experimental autoimmune encephalomyelitis. | J Neuroinflammation | 2025 | 40082912 | PubTator, text mining | PubMed |
| Identification and functional characterization of m1A-related genes in colorectal cancer: implications for prognosis, immune infiltration, and therapeutic strategies. | Front Oncol | 2025 | 40040720 | PubTator, text mining | PubMed |
| Loop diuretics mitigate juvenile immobilization treatment-induced hippocampal dysfunction. | Eur J Pharmacol | 2025 | 40023355 | PubTator, text mining | PubMed |
| Computational Modeling of Pharmaceuticals with an Emphasis on Crossing the Blood-Brain Barrier. | Pharmaceuticals (Basel) | 2025 | 40006031 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6558/papers?page=5